Difference between revisions of "Levamisole (Ergamisol)"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
This agent is not commercially available in the United States and is included for historic purposes only. | This agent is not commercially available in the United States and is included for historic purposes only. | ||
| − | + | ==Diseases for which it is used== | |
| + | *[[Colon cancer]] | ||
| + | *[[Rectal cancer]] | ||
| + | ==Also known as== | ||
| + | *'''Brand name:''' Ergamisol | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
| Line 8: | Line 12: | ||
[[Category:Drugs FDA approved in 1990]] | [[Category:Drugs FDA approved in 1990]] | ||
| + | [[Category:Discontinued]] | ||
Revision as of 20:19, 23 July 2018
This agent is not commercially available in the United States and is included for historic purposes only.
Diseases for which it is used
Also known as
- Brand name: Ergamisol